ROSSARIBSERossari Biotech LtdMediumNeutral
Announced Tue, 2 Sept · 10:48 IST

The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Yash Sunil Chari

Ownership Changes View source PDF

ROSSARI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

The BSE has received a disclosure under Regulation 10(6) of SEBI's Substantial Acquisition of Shares & Takeovers (SAST) Regulations, 2011, filed by Yash Sunil Chari. This regulation requires shareholders to report acquisitions of shares made under the creeping acquisition route (i.e., incremental purchases that do not trigger the mandatory open-offer requirement). The headline does not specify the number of shares acquired, whether the acquirer is a promoter, or the resulting shareholding level. No further details on transaction size or direction were provided in the filing notice.

Likely market impact

Routine procedural compliance filing with no immediate material effect on the stock. Investors should watch for follow-up disclosures with transaction details to assess if the acquisition is sizeable enough to influence shareholding patterns.